Expert Reviews Guidelines for Anticoagulants in Patients Ages 80 and Older or With End-Stage Renal Disease

Dec 8, 2021

Rivaroxaban and apixaban are the most commonly prescribed direct oral anticoagulants, although they may be most effective in different populations.

In an interview with Pharmacy Times, Zachary Noel, PharmD, BCCP, discussed the presentation at the American Society of Health-System Pharmacists 2021 Midyear Meeting titled "Direct Oral Anticoagulant Dilemmas: Stroke Prevention for Atrial Fibrillation in the Oldest Old and Patients with End-Stage Renal Disease."

In the interview, Noel discussed the most commonly prescribed anticoagulants and recommendations for which to prescribe in various populations, including patients ages 80 and older and those with end-stage renal disease.

Expert Reviews Guidelines for Anticoagulants in Patients Ages 80 and Older or With End-Stage Renal Disease

FDA Expands Use of Illuccix Kit to Patient Selection for PSMA-Directed Radioligand Therapy

On The Shelf - Career Wellness

Community-associated C. Difficile Infection Is Rising; Disease Carries Significant Social, Economic Burden

Pharmacy Focus: Student Edition - The Granada Statements

GSK Announces Positive Pivotal Phase 3 Data for 5-in-1 Meningococcal Vaccine Candidate

Omicron Less Likely Than Early Variants to Cause Symptoms of Long COVID-19

FDA Expands Use of Illuccix Kit to Patient Selection for PSMA-Directed Radioligand Therapy

On The Shelf - Career Wellness

Community-associated C. Difficile Infection Is Rising; Disease Carries Significant Social, Economic Burden

Pharmacy Focus: Student Edition - The Granada Statements

GSK Announces Positive Pivotal Phase 3 Data for 5-in-1 Meningococcal Vaccine Candidate

Omicron Less Likely Than Early Variants to Cause Symptoms of Long COVID-19

FDA Expands Use of Illuccix Kit to Patient Selection for PSMA-Directed Radioligand Therapy

On The Shelf - Career Wellness

Community-associated C. Difficile Infection Is Rising; Disease Carries Significant Social, Economic Burden

Pharmacy Focus: Student Edition - The Granada Statements

GSK Announces Positive Pivotal Phase 3 Data for 5-in-1 Meningococcal Vaccine Candidate

Omicron Less Likely Than Early Variants to Cause Symptoms of Long COVID-19